Pr Christophe Massard, Oncologist, bladder expert, prostate expert

Specialty

Oncologist, bladder expert, prostate expert

Title

Head of the Early Trials Department (DITEP)

Hospital

Gustave Roussy (Villejuif)

Latest articles

Monocyte-lineage tumor infiltration predicts immunoradiotherapy response in advanced pretreated soft-tissue sarcoma: phase 2 trial results. (Mar 17, 2025)
Low-dose irradiation of the gut improves the efficacy of PD-L1 blockade in metastatic cancer patients. (Mar 10, 2025)
AZD8701, an Antisense Oligonucleotide Targeting FOXP3 mRNA, as Monotherapy and in Combination with Durvalumab: Phase I trial in Patients with Advanced Solid Tumors. (Feb 12, 2025)
Prognostic Impact of Oncogenic Fibroblast Growth Factor Receptor Alterations in Patients With Advanced Solid Tumors in a Real-World Setting. (Feb 1, 2025)
Final Overall Survival and Molecular Data Associated with Clinical Outcomes in Patients Receiving Ipatasertib and Abiraterone in the Phase 3 IPATential150 Trial. (Jan 29, 2025)